PFIZER
Back to Balance Sheet
|
PFIZER Last 5 Year Total Non-Current Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹55 Cr | ₹33 Cr | ₹38 Cr | ₹136 Cr | ₹85 Cr |
What is the latest Total Non-Current Liabilities ratio of PFIZER ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹55 Cr |
| Mar2024 | ₹33 Cr |
| Mar2023 | ₹38 Cr |
| Mar2022 | ₹136 Cr |
| Mar2021 | ₹85 Cr |
How is Total Non-Current Liabilities of PFIZER Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹55 Cr | 67.65 | |
| Mar2024 | ₹33 Cr | -14.76 | |
| Mar2023 | ₹38 Cr | -71.81 | |
| Mar2022 | ₹136 Cr | 60.16 | |
| Mar2021 | ₹85 Cr | - | |
Compare Total Non-Current Liabilities of peers of PFIZER
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| PFIZER | ₹21,967.1 Cr | -1.7% | -3.5% | -4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹422,631.0 Cr | 1.9% | -0.8% | -3.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹175,111.0 Cr | 3.2% | 4.8% | 12.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹136,228.0 Cr | 6.3% | 8.9% | 15.8% | Stock Analytics | |
| CIPLA | ₹117,983.0 Cr | -3.3% | -2% | -1.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,782.0 Cr | -3.8% | -3.1% | -8% | Stock Analytics | |
PFIZER Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| PFIZER | -1.7% |
-3.5% |
-4% |
| SENSEX | -1.2% |
-1.1% |
6.3% |
You may also like the below Video Courses